Among 281 patients with essential thrombocythemia and calreticulin (CALR) mutation, we found a variant allele frequency of ≥60% to be associated with significantly shortened myelofibrosis-free survival, mostly apparent with CALR type-1 and CALR type-indeterminate mutations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1182/blood.2023023428 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!